Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment. (6th November 2014) - Yopp, Adam; Kallinteris, Nikoletta; Huang, Xianming; Shan, Joe; Menander, Kerstin; Freimark, Bruce; Hutchins, Jeff; King, Steve; Gabrilovich, Dmitry I; Brekken, Rolf